MPEP, mGLU5 receptor antagonist, regulates NPYmRNA expression in hippocampal and amygdalar neurons

Polish Journal of Pharmacology

Volumn 56, Issue 6, 2004, Pages 709-718

  Śmiałowska, Maria ^a   Wierońska, Joanna M ^a   Brański, Piotr ^a   Obuchowicz, Ewa ^b   Pilc, Andrzej ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b UNIVERSITY OF SILESIA   (Poland)

Author keywords

Amygdala; Hippocampus; MPEP; NPY; NPYmRNA

Indexed keywords

2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; GLUTAMATE RECEPTOR 5; MESSENGER RNA; NEUROPEPTIDE Y; NEUROPEPTIDE Y1 RECEPTOR;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG RECEPTOR BINDING; HIPPOCAMPUS; HISTOPATHOLOGY; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; RAT; RAT STRAIN; RECEPTOR DOWN REGULATION; TISSUE DISTRIBUTION; TRANQUILIZING ACTIVITY;

AMYGDALA; ANIMALS; ANTI-ANXIETY AGENTS; GENE EXPRESSION REGULATION; HIPPOCAMPUS; MALE; NEURONS; NEUROPEPTIDE Y; PYRIDINES; RATS; RATS, WISTAR; RECEPTORS, METABOTROPIC GLUTAMATE; RNA, MESSENGER;

EID: 14244259183     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Bijak M, Śmiałowska M: Effects of neuropeptide Y on evoked potentials in the CA1 region and the dentate gyrus of the rat hippocampal slice. Pol J Pharmacol, 1995, 47, 333-338.
2. Bruno V, Copani A, Battaglia G, Raffaele R, Shinozaki H, Nicoletti F: Protective effect of the metabotropic glutamate receptor agonist, DCG-IV, against excitotoxic neuronal cell death. Eur J Pharmacol, 1994, 256, 109-112.
3. Bruno V, Copani A, Knopfel T, Kuhn R, Casabona G, Dellalbadi P, Condorelli DF et al.: Activation of metabotropic glutamate receptors coupled to inositol phospholipid hydrolysis amplifies NMDA-induced neuronal degeneration in cultured cortical cells. Neuropharmacology, 1995, 34, 1089-1098.
4. Chojnacka-Wójcik E, Kłodzińska A, Pilc A: Glutamate receptor ligands as anxiolytics. Curr Opinion Investig Drugs, 2001, 2, 1112-1119.
5. Chronwall BM, DiMaggio DA, Massari VJ, Pickel VM, Ruggiero DA, O'Donohue TL: The anatomy of neuropeptide Y-containing neurons in rat brain. Neuroscience, 1982, 15, 1159-1181.
6. Colmers WF: Modulation of synaptic transmission in hippocampus by neuropeptide Y: presynaptic actions. Ann NY Acad Sci, 1990, 611, 206-218.
7. Conn PJ, Pin JP: Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol, 1997, 37, 205-237.
8. Cotman CW, Kahle JS, Miller SE, Ułas J, Bridger RJ: Excitatory amino acid neurotransmission. In: Psychopharmacology: The Forth Generation of Progress. Ed. Bloom FE, Kupfer DJ, Raven Press, Ltd, New York, 1995, 75-85.
9. De Quidt ME, Emson PC: Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system. II. Immunohistochemical analysis. Neuroscience, 1986, 18, 545-618.
10. Farb C, Aoki C, Milner T, Kaneko T, LeDoux J: Glutamate immunoreactive terminals in the lateral amygdaloid nucleus: a possible substrate for emotional memory. Brain Res, 1992, 593, 145-158.
11. Gasparini F, Lingelhöhl K, Stoehr N, Flor PJ, Heinrich M, Vranesic I, Biollaz M et al.: 2-Methyl-6-(phenylethyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist. Neuropharmacology, 1999, 38, 1493-1503.
12. Gołembiowska K, Konieczny J, Ossowska K, Wolfarth S: The role of striatal metabotropic glutamate receptors in degeneration of dopamine neurons: review article. Amino Acids, 2002, 23, 199-205.
13. Gray JA: Précis of the neuropsychology of anxiety: an enquiry into the functions of the septo-hippocampal system. Behav Brain Sci, 1982, 5, 469-534.
14. Gray TS, Morley JE: Neuropeptide Y: anatomical distribution and possible function in mammalian nervous system. Life Sci, 1986, 38, 389-401.
15. Gustafson EL, Card JP, Moore RY: Neuropeptide Y localization in the rat amygdaloid complex. J Comp Neurol, 1986, 251, 349-362.
16. Heilig M, McLeod M, Brot M, Heinrichs SC, Menzaghi F, Koob GF, Britton KT: Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects. Neuropsychopharmacology, 1993, 8, 357-363.
17. Heilig M, Soderpalm B, Engel JA, Widerlov E: Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models. Psychopharmacology, 1989, 98, 524-529.
18. Kask A, Eller M, Oreland L, Harro J: Neuropeptide Y attenuates the effect of locus coeruleus denervation by DSP4 treatment on social behavior in the rat. Neuropeptides, 2000, 34, 58-61.
19. Kerkerian L, Salin P, Nieoullon A: Pharmacological characterization of dopaminergic influence on expression of neuropeptide Y immunoreactivity by rat striatal neurons. Neuroscience, 1988, 26, 809-817.
20. Kim SK, Kwon GY, Shin SW, Choe BK: Expression of neuropeptide Y by glutamatergic stimulation in rat C6 glioma cells. J Neurochem Int, 2000, 36, 19-26.
21. Klapstein GJ, Colmers WF: Neuropeptide Y suppresses epileptiform activity in rat hippocampus in vitro. J Neurophysiol, 1997, 78, 1651-1661.
22. Knopfel T, Kuhn R, Allgeier H: Metabotropic glutamate receptors: novel targets for drug development. J Med Chem, 1995, 38, 1417-1424.
23. Marksteiner J, Ortler M, Bellmann R, Sperk G: Neuropeptide Y biosynthesis is markedly induced in mossy fibers during temporal lobe epilepsy in the rat. Neurosci Lett, 1990, 112, 143-148.
24. McDonald JW, Fix AS, Tizzano JP, Schoepp DD: Seizures and brain injury in neonatal rats induced by 1S,3R-ACPD, a metabotropic glutamate receptor agonist. J Neurosci, 1993, 13, 4445-4455.
25. Neugebauer V, Li W, Bird GC, Bhave G, Gereau RW: Synaptic plasticity in the amygdala in a model of arthritic pain: differential roles of metabotropic glutamate receptors 1 and 5. J Neurosci, 2003, 23, 52-63.
26. Nicoletti F, Bruno V, Copani A, Casabona G, Knopfel T: Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders? Trends Neurosci, 1996, 19, 267-271.
27. Ossowska K, Konieczny J, Wardas K, Gołembiowska K, Wolfarth S, Pilc A: The role of striatal metabotropic glutamate receptors in Parkinson's disease. Amino Acids, 2002, 23, 193-198.
28. Ossowska K, Konieczny J, Wolfarth S, Wierońska J, Pilc A: Blockade of the metabotropic glutamate receptor subtype 5 (mGluR5) produces antiparkinsonian-like effects in rats. Neuropharmacology, 2001, 41, 413-420.
29. Paxinos G, Watson C: The rat brain in stereotaxic coordinates. Academic Press, New York, 1986.
30. Pilc A, Brański P, Pałucha A, Tokarski A, Bijak M: Antidepressant treatment influences group I of glutamate metabotropic receptors in slices from hippocampal CA1 region. Eur J Pharmacol, 1998, 349, 83-87.
31. Pilc A, Kłodzińska A, Brański P, Nowak G, Pał ucha A, Szewczyk B, Tatarczyńska E et al.: Multiple MPEP administrations evoke anxiolytic- and antidepressant-like effects in rats. Neuropharmacology, 2002, 43, 181-187.
32. Pin JP, Duvoisin R: Review: neurotransmitter receptors. I. The metabotropic glutamate receptors: structure and functions. Neuropharmacology, 1995, 34, 1-26.
33. Rodrigues SM, Bauer EP, Farb CR, Schafe GE, LeDoux JE: The group I metabotropic glutamate receptor mGluR5 is required for fear memory formation and long-term potentiation in the lateral amygdala. J Neurosci, 2002, 22, 5219-5229.
34. Sajdyk TJ, Vandergriff MG, Gehlert DR: Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test. Eur J Pharmacol, 1999, 368, 143-147.
35. Salin P, Kerkerian L, Nieoullon A: Expression of neuropeptide Y immunoreactivity in the rat nucleus accumbens is under the influence of the dopaminergic mesencephalic pathway. Exp Brain Res, 1990, 81, 363-371.
36. Schwarzer C, Sperk G: Glutamate-stimulated neuropeptide Y mRNA expression in the rat dentate gyrus: a prominent role of metabotropic glutamate receptors. Hippocampus, 1998, 8, 274-288.
37. Shigemoto R, Kinoshita A, Wada E, Nomura S, Ohishi H, Takada M, Flor PJ et al: Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus. J Neurosci, 1997, 17, 7503-7522.
38. Śmiałowska M: Neuropeptide Y immunoreactivity in the locus coeruleus of the rat brain. Neuroscience, 1988, 25, 123-131.
39. Śmiałowska M: An inhibitory dopaminergic regulation of the neuropeptide Y immunoreactivity expression in the rat cerebral cortex neurons. Neuroscience, 1995, 66, 569-595.
40. Śmiałowska M, Bajkowska M: Activation of metabotropic glutamate receptors increases neuropeptide Y expression in the rat hippocampus. Immunohistochemical study. Pol J Pharmacol, 1997, 49, 357-362.
41. Śmiałowska M, Bajkowska M, Przewłocka B, Maj M, Turchan J, Przewłocki R: Effect of 6-hydroxydopamine on neuropeptide Y and corticotropin-releasing factor expression in rat amygdala. Neuroscience, 1999, 94, 1125-1132
42. Śmiałowska M, Obuchowicz E, Turchan J, Herman ZS, Przewłocki R: Clonidine administration increases neuropeptide Y immunoreactivity and neuropeptide Y mRNA in the rat cerebral cortex neurons. Neuropeptides, 1997, 31, 203-207.
43. Śmiałowska M, Szewczyk B, Brański P, Wieroń ska JM, Pałucha A, Bajkowska M, Pilc A: Effect of chronic imipramine or electroconvulsive shock on the expression of mGluR1a and mGluR5a immunoreactivity in rat brain hippocampus. Neuropharmacology, 2002, 42, 1016-1023.
44. Śmiałowska M, Wierońska JM, Szewczyk B: Neuroprotective effect of NPY on kainate neurotoxicity in the hippocampus. Pol J Pharmacol, 2003, 55, 979-986.
45. Tatarczyńska E, Kłodzińska A, Kroczka B, Chojnacka-Wójcik E, Pilc A: The antianxiety-like effects of antagonists of group I and agonists of group II and III metabotropic glutamate receptors after intrahippocampal administration. Psychopharmacology, 2001, 158, 94-99.
46. Tirassa P, Lundberg T, Stenfors C, Bracci-Laudiero L, Theodorson E, Aloe L: Monosodium glutamate increases NGF and NPY concentration in rat hypothalamus and pituitary. Neuroreport, 1995, 6, 2450-2452.
47. Warner MR, Senanayake PS, Ferrario CM, Levy MN: Sympathetic stimulation-evoked overflow of norepinephrine and neuropeptide Y from the heart. Circ Res, 1991, 69, 455-465.
48. Wierońska JM, Śmiałowska M, Brański P, Gasparini F, Kłodzińska A, Szewczyk B, Pałucha A et al.: In the amygdala anxiolytic action of mGlu5 receptors antagonist MPEP involves neuropeptide Y but not GABAA signaling. Neuropsychopharmacology, 2004, 29, 514-521.
49. Young WS 3rd, Bonner TI, Brann MR: Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNA in the rat forebrain. Proc Natl Acad Sci USA, 1986, 83, 9827-9831.